142 related articles for article (PubMed ID: 30476509)
1. Models for Antibody Behavior in Hydrophobic Interaction Chromatography and in Self-Association.
Hebditch M; Roche A; Curtis RA; Warwicker J
J Pharm Sci; 2019 Apr; 108(4):1434-1441. PubMed ID: 30476509
[TBL] [Abstract][Full Text] [Related]
2. Homology modeling and structure-based design improve hydrophobic interaction chromatography behavior of integrin binding antibodies.
Jetha A; Thorsteinson N; Jmeian Y; Jeganathan A; Giblin P; Fransson J
MAbs; 2018; 10(6):890-900. PubMed ID: 30110240
[TBL] [Abstract][Full Text] [Related]
3. Solubility Challenges in High Concentration Monoclonal Antibody Formulations: Relationship with Amino Acid Sequence and Intermolecular Interactions.
Pindrus M; Shire SJ; Kelley RF; Demeule B; Wong R; Xu Y; Yadav S
Mol Pharm; 2015 Nov; 12(11):3896-907. PubMed ID: 26407030
[TBL] [Abstract][Full Text] [Related]
4. Developability Assessment of Engineered Monoclonal Antibody Variants with a Complex Self-Association Behavior Using Complementary Analytical and in Silico Tools.
Shan L; Mody N; Sormani P; Rosenthal KL; Damschroder MM; Esfandiary R
Mol Pharm; 2018 Dec; 15(12):5697-5710. PubMed ID: 30395473
[TBL] [Abstract][Full Text] [Related]
5. Biophysical and Sequence-Based Methods for Identifying Monovalent and Bivalent Antibodies with High Colloidal Stability.
Alam ME; Geng SB; Bender C; Ludwig SD; Linden L; Hoet R; Tessier PM
Mol Pharm; 2018 Jan; 15(1):150-163. PubMed ID: 29154550
[TBL] [Abstract][Full Text] [Related]
6. Molecular Characterization of Two Monoclonal Antibodies against the Same Epitope on B-Cell Receptor Associated Protein 31.
Kim WT; Shin S; Hwang HJ; Kim MK; Jung HS; Park H; Ryu CJ
PLoS One; 2016; 11(12):e0167527. PubMed ID: 27907150
[TBL] [Abstract][Full Text] [Related]
7. Five computational developability guidelines for therapeutic antibody profiling.
Raybould MIJ; Marks C; Krawczyk K; Taddese B; Nowak J; Lewis AP; Bujotzek A; Shi J; Deane CM
Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4025-4030. PubMed ID: 30765520
[TBL] [Abstract][Full Text] [Related]
8. Arginine mutations in antibody complementarity-determining regions display context-dependent affinity/specificity trade-offs.
Tiller KE; Li L; Kumar S; Julian MC; Garde S; Tessier PM
J Biol Chem; 2017 Oct; 292(40):16638-16652. PubMed ID: 28778924
[TBL] [Abstract][Full Text] [Related]
9. Modeling the impact of amino acid substitution in a monoclonal antibody on cation exchange chromatography.
Saleh D; Hess R; Ahlers-Hesse M; Beckert N; Schönberger M; Rischawy F; Wang G; Bauer J; Blech M; Kluters S; Studts J; Hubbuch J
Biotechnol Bioeng; 2021 Aug; 118(8):2923-2933. PubMed ID: 33871060
[TBL] [Abstract][Full Text] [Related]
10. Optimal charged mutations in the complementarity-determining regions that prevent domain antibody aggregation are dependent on the antibody scaffold.
Perchiacca JM; Lee CC; Tessier PM
Protein Eng Des Sel; 2014 Feb; 27(2):29-39. PubMed ID: 24398633
[TBL] [Abstract][Full Text] [Related]
11. Impact of Tryptophan Oxidation in Complementarity-Determining Regions of Two Monoclonal Antibodies on Structure-Function Characterized by Hydrogen-Deuterium Exchange Mass Spectrometry and Surface Plasmon Resonance.
Hageman T; Wei H; Kuehne P; Fu J; Ludwig R; Tao L; Leone A; Zocher M; Das TK
Pharm Res; 2018 Dec; 36(1):24. PubMed ID: 30536043
[TBL] [Abstract][Full Text] [Related]
12. Molecular modeling of cardiac glycoside binding by the human sequence monoclonal antibody 1B3.
Paula S; Monson N; Ball WJ
Proteins; 2005 Aug; 60(3):382-91. PubMed ID: 15971203
[TBL] [Abstract][Full Text] [Related]
13. Binding symmetry and surface flexibility mediate antibody self-association.
Schrag JD; Picard MÈ; Gaudreault F; Gagnon LP; Baardsnes J; Manenda MS; Sheff J; Deprez C; Baptista C; Hogues H; Kelly JF; Purisima EO; Shi R; Sulea T
MAbs; 2019 Oct; 11(7):1300-1318. PubMed ID: 31318308
[TBL] [Abstract][Full Text] [Related]
14. Aspartate isomerization in the complementarity-determining regions of two closely related monoclonal antibodies.
Wakankar AA; Borchardt RT; Eigenbrot C; Shia S; Wang YJ; Shire SJ; Liu JL
Biochemistry; 2007 Feb; 46(6):1534-44. PubMed ID: 17279618
[TBL] [Abstract][Full Text] [Related]
15. Rational design of viscosity reducing mutants of a monoclonal antibody: hydrophobic versus electrostatic inter-molecular interactions.
Nichols P; Li L; Kumar S; Buck PM; Singh SK; Goswami S; Balthazor B; Conley TR; Sek D; Allen MJ
MAbs; 2015; 7(1):212-30. PubMed ID: 25559441
[TBL] [Abstract][Full Text] [Related]
16. Aggregation-resistant domain antibodies engineered with charged mutations near the edges of the complementarity-determining regions.
Perchiacca JM; Ladiwala AR; Bhattacharya M; Tessier PM
Protein Eng Des Sel; 2012 Oct; 25(10):591-601. PubMed ID: 22843678
[TBL] [Abstract][Full Text] [Related]
17. An alternative assay to hydrophobic interaction chromatography for high-throughput characterization of monoclonal antibodies.
Estep P; Caffry I; Yu Y; Sun T; Cao Y; Lynaugh H; Jain T; Vásquez M; Tessier PM; Xu Y
MAbs; 2015; 7(3):553-61. PubMed ID: 25790175
[TBL] [Abstract][Full Text] [Related]
18. Structural classification of CDR-H3 revisited: a lesson in antibody modeling.
Kuroda D; Shirai H; Kobori M; Nakamura H
Proteins; 2008 Nov; 73(3):608-20. PubMed ID: 18473362
[TBL] [Abstract][Full Text] [Related]
19. Estimation of the Viscosity of an Antibody Solution from the Diffusion Interaction Parameter.
Shimomura T; Sekiguchi M; Honda R; Yamazaki M; Yokoyama M; Uchiyama S
Biol Pharm Bull; 2022; 45(9):1300-1305. PubMed ID: 36047198
[TBL] [Abstract][Full Text] [Related]
20. Hydrogen exchange mass spectrometry reveals protein interfaces and distant dynamic coupling effects during the reversible self-association of an IgG1 monoclonal antibody.
Arora J; Hickey JM; Majumdar R; Esfandiary R; Bishop SM; Samra HS; Middaugh CR; Weis DD; Volkin DB
MAbs; 2015; 7(3):525-39. PubMed ID: 25875351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]